“I would not be alive today”: Victoria Rose credits recent developments in APML research for saving her life
In April 2022, Victoria Rose was diagnosed with a rare sub-type of acute myeloid leukaemia (AML) called acute promyelocytic leukaemia (APML). Heading into 2022 was supposed to be an exciting time for Victoria Rose. But in early April, Victoria…
Read more